Revenue: The sum of all revenue fields included for a company's operating activities.
Aurinia Pharmaceuticals Inc (AUPH) had Revenue of $77.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$77.11M |
$210.79M |
|
$8.80M |
|
$68.31M |
|
$48.95M |
|
$28.16M |
|
$7.53M |
|
$35.69M |
|
$35.69M |
|
$210.79M |
|
$210.79M |
|
$210.79M |
|
$210.79M |
|
$28.16M |
|
$33.03M |
|
134.37M |
|
138.70M |
|
$1.57 |
|
$1.52 |
|
| Balance Sheet Financials | |
$491.97M |
|
$2.11M |
|
$259.62M |
|
$751.59M |
|
$93.72M |
|
$52.32M |
|
$76.53M |
|
$170.26M |
|
$581.33M |
|
$577.57M |
|
$581.33M |
|
132.32M |
|
| Cash Flow Statement Financials | |
$135.66M |
|
$-32.77M |
|
$-106.11M |
|
$83.43M |
|
$80.21M |
|
$-3.22M |
|
$14.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.25 |
|
-- |
|
-- |
|
0.08 |
|
0.12 |
|
88.59% |
|
36.52% |
|
36.52% |
|
-- |
|
46.28% |
|
273.35% |
|
$135.41M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.19 |
|
1.86 |
|
48.38 |
|
36.26% |
|
36.50% |
|
28.05% |
|
33.27% |
|
$4.39 |
|
$0.98 |
|
$0.98 |
|